The Intrinsic Pathway does not Contribute to Activation of Coagulation in Mice Bearing Human Pancreatic Tumors Expressing Tissue Factor

Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty

(2020) Jeffrey I. Weitz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Model‐dependent contributions of FXII and FXI to venous thrombosis in mice

(2020) Steven P Grover et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size

(2017) Y. Hisada et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays

(2016) Yohei Hisada et al.   THROMBOSIS RESEARCH

The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis

(2015) K. F. Nickel et al.   BLOOD

Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice

(2015) J. E. Geddings et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

(2015) Harry R. Büller et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epidemiology of cancer-associated venous thrombosis

(2013) J. F. Timp et al.   BLOOD

In vivo roles of factor XII

(2012) T. Renne et al.   BLOOD

Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer

(2012) J.-G. Wang et al.   BLOOD

Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo

(2012) Marie-Luise von Brühl et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding

(2011) A. S. Revenko et al.   BLOOD

Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk

(2010) H. Zhang et al.   BLOOD

Tumor-Derived Tissue Factor-Bearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy

(2009) J. I. Zwicker et al.   CLINICAL CANCER RESEARCH

Assessing Risk of Venous Thromboembolism in the Patient With Cancer

(2009) Alok A. Khorana et al.   JOURNAL OF CLINICAL ONCOLOGY

Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation

(2008) M. DAVILA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS